Mediterranean Fish Vaccine Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - Vaccine Type (Inactivated Vaccine, Live-attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccine), Route of Administration (Immersion Vaccine, Injection Vaccine, and Oral Vaccine), Species (Turbot, European Anchovy and Seabass, Salmon, Mediterranean Sea Bass, Common Dentex and Common Pandora, Sea Bream, Rainbow Wrasse, Sparus Aurata, Trout, Mediterranean Swordfish and Bluefin Tuna, Grouper and Amberjack, and Others), and Country

No. of Pages: 199
Report Code: BMIRE00028804
Category: Life Sciences
Mediterranean Fish Vaccine Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Mediterranean Fish Vaccine Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Mediterranean Fish Vaccine Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Mediterranean Fish Vaccine Market Regional Analysis

6.2 Mediterranean Fish Vaccine Market Revenue 2020-2030 (US$ Million)
6.3 Mediterranean Fish Vaccine Market Forecast Analysis

7. Mediterranean Fish Vaccine Market Analysis – by Vaccine Type

7.1 Inactivated Vaccine
  • 7.1.1 Overview
  • 7.1.2 Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Live-attenuated Vaccine
  • 7.2.1 Overview
  • 7.2.2 Live-attenuated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Toxoid Vaccine
  • 7.3.1 Overview
  • 7.3.2 Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Subunit Vaccine
  • 7.4.1 Overview
  • 7.4.2 Subunit Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Conjugate Vaccine
  • 7.5.1 Overview
  • 7.5.2 Conjugate Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.6 Recombinant Vector Vaccine
  • 7.6.1 Overview
  • 7.6.2 Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Mediterranean Fish Vaccine Market Analysis – by Route of Administration

8.1 Immersion Vaccine
  • 8.1.1 Overview
  • 8.1.2 Immersion Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Injection Vaccine
  • 8.2.1 Overview
  • 8.2.2 Injection Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Oral Vaccine
  • 8.3.1 Overview
  • 8.3.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Mediterranean Fish Vaccine Market Analysis – by Species

9.1 Turbot
  • 9.1.1 Overview
  • 9.1.2 Turbot: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 European Anchovy and Seabass
  • 9.2.1 Overview
  • 9.2.2 European Anchovy and Seabass: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Salmon
  • 9.3.1 Overview
  • 9.3.2 Salmon: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Mediterranean Sea Bass
  • 9.4.1 Overview
  • 9.4.2 Mediterranean Sea Bass: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Common Dentex and Common Pandora
  • 9.5.1 Overview
  • 9.5.2 Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Sea Bream
  • 9.6.1 Overview
  • 9.6.2 Sea Bream: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.7 Rainbow Wrasse
  • 9.7.1 Overview
  • 9.7.2 Rainbow Wrasse: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.8 Sparus Aurata
  • 9.8.1 Overview
  • 9.8.2 Sparus Aurata: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.9 Trout
  • 9.9.1 Overview
  • 9.9.2 Trout: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.10 Mediterranean Swordfish and Bluefin Tuna
  • 9.10.1 Overview
  • 9.10.2 Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.11 Grouper and Amberjack
  • 9.11.1 Overview
  • 9.11.2 Grouper and Amberjack: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Mediterranean Fish Vaccine Market – Mediterranean Analysis

10.1 Overview

10.2 Mediterranean
  • 10.2.1 Mediterranean Fish Vaccine Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.2.1.1 Mediterranean Fish Vaccine Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Mediterranean: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Vaccine Type
    • 10.2.1.1.2 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Route of Administration
    • 10.2.1.1.3 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Species

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Zoetis Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Merck & Co Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 HIPRA SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 ICTYODEV SAS
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Acuipharma Aquaculture Health SL
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Phibro Animal Health Corp
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Vaxxinova International BV
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Kyoto Biken Laboratories Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Elanco Animal Health Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Ceva SA
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Mediterranean Fish Vaccine Market

  • Zoetis Inc.
  • Merck & Co Inc
  • HIPRA SA
  • ICTYODEV SAS
  • Acuipharma Aquaculture Health SL
  • Phibro Animal Health Corp
  • Vaxxinova International BV
  • Kyoto Biken Laboratories Inc
  • Elanco Animal Health Inc
  • Ceva SA
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)